Ginkgo Bioworks Holdings, Inc. (DNA) — Analysis Summary
Ginkgo Bioworks Holdings, Inc. (DNA) has a market cap of $597.07M with year-over-year revenue growth of -25.1%. Net margin stands at -183.8%. The stock trades at a P/E ratio of -2.0.
Key Takeaways
- Revenue changed -25.1% year-over-year
- Net margin of -183.8%
- P/E ratio of -2.0
Compared to other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, DNA posted revenue growth of -25.1% and trades at a P/E of -2.0.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.